Manulife (Manufacturers Life Insurance)
SEEL

Manulife (Manufacturers Life Insurance)’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8
Closed -$52 – 3207
2021
Q4 		$52 Buy
8
+4
+100% +$30.7K ﹤0.01% 3092
2021
Q3 		$33K Sell
4
-9
-69% -$77.3K ﹤0.01% 3125
2021
Q2 		$128K Buy
+13
New +$214K ﹤0.01% 3200
2017
Q3 		– Hold
0
– – – 4359
2017
Q2 		– Hold
0
– – – 4469
2017
Q1 		– Hold
0
– – – 4102
2016
Q4 		– Hold
0
– – – 4250
2016
Q3 		– Hold
0
– – – 4200
2016
Q2 		– Hold
0
– – – 4028
2016
Q1 		– Hold
0
– – – 3890
2015
Q4 		– Hold
0
– – – 3711
2015
Q3 		– Hold
0
– – – 3654
2015
Q2 		– Hold
0
– – – 3632
2015
Q1 		– Hold
0
– – – 3592
2014
Q4 		– Hold
0
– – – 3658
2014
Q3 		– Hold
0
– – – 3599
2014
Q2 		– Hold
0
– – – 3643
2014
Q1 		– Hold
0
– – – 3590
2013
Q4 		– Hold
0
– – – 3681
2013
Q3 		– Hold
0
– – – 3539
2013
Q2 		– Hold
0
– – – 3417

Other funds holding SEEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SEEL Position: Q1 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2022, closing a stake of 8 shares — an estimated $52 sold.

Manulife (Manufacturers Life Insurance) first reported a position in SEEL in Q2 2021 and held it in 3 quarters. The position peaked at $128K in Q2 2021. 77 funds tracked by Wall St. Rank hold SEEL as of Q1 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 8 Seelos Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $52.
  • Manulife (Manufacturers Life Insurance) first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Seelos Therapeutics, Inc. Common Stock position peaked at $128K in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.